Literature DB >> 23339728

Patterns of nonadherence to antihypertensive therapy in primary care.

Larissa Grigoryan1, Valory N Pavlik, David J Hyman.   

Abstract

Nonadherence to medications is an important cause of poor blood pressure control. Long-acting antihypertensive agents could theoretically be beneficial in partially adherent patients, who are commonly seen in contemporary practice. Little has been reported about the duration of drug holidays (DHs) in treated hypertensives outside of generally compliant patients in phase 4 clinical trials. The authors described patterns of nonadherence to single and multiple antihypertensives in a random sample of 120 primary care patients with uncontrolled hypertension. Adherence to up to 3 antihypertensives was measured by electronic monitoring. Frequencies of single-day omissions and DHs of 2 consecutive days (DH2), 3 days (DH3), or ≥4 days (DH≥4) for each drug were calculated. Overall, 89 (74%) of patients had at least a 1-day omission. A single day omission was found in 61.4% of the patients taking 1 drug, followed by DH≥4 (28.1%), DH2 (26.3%), and DH3 (8.8%). In patients using multiple drugs, single-day omissions were also most common, followed by DH≥4, DH2, and DH3. Omissions of ≤3 days comprise on average 74% of all omissions. Although encouraging full adherence remains important, it may be prudent to prescribe long-acting antihypertensive agents, which can compensate for the majority of dose omissions.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23339728      PMCID: PMC3711402          DOI: 10.1111/jch.12030

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  20 in total

Review 1.  Clinical practice. Resistant or difficult-to-control hypertension.

Authors:  Marvin Moser; John F Setaro
Journal:  N Engl J Med       Date:  2006-07-27       Impact factor: 91.245

2.  Compliance in hypertension.

Authors:  M Burnier
Journal:  EDTNA ERCA J       Date:  2005 Jul-Sep

3.  Predictors of antihypertensive medication adherence in two urban health-care systems.

Authors:  Larissa Grigoryan; Valory N Pavlik; David J Hyman
Journal:  Am J Hypertens       Date:  2012-03-22       Impact factor: 2.689

4.  Comparative effects of amlodipine and nifedipine GITS during treatment and after missing two doses.

Authors:  R H Hernández; M J Armas-Hernández; J A Chourio; M C Armas-Padilla; L López; M Alvarez; B Pacheco
Journal:  Blood Press Monit       Date:  2001-02       Impact factor: 1.444

5.  State of disparities in cardiovascular health in the United States.

Authors:  George A Mensah; Ali H Mokdad; Earl S Ford; Kurt J Greenlund; Janet B Croft
Journal:  Circulation       Date:  2005-03-15       Impact factor: 29.690

6.  Impact of medication adherence on hospitalization risk and healthcare cost.

Authors:  Michael C Sokol; Kimberly A McGuigan; Robert R Verbrugge; Robert S Epstein
Journal:  Med Care       Date:  2005-06       Impact factor: 2.983

7.  Prolonged antihypertensive effect of amlodipine: a prospective double-blind randomized study.

Authors:  P Biston; C Mélot; J P Degaute; D Clement; A Quoidbach
Journal:  Blood Press       Date:  1999       Impact factor: 2.835

8.  Persistence of anti-hypertensive effect after 'missed doses' of calcium antagonist with long (amlodipine) vs short (diltiazem) elimination half-life.

Authors:  F H Leenen; A Fourney; G Notman; J Tanner
Journal:  Br J Clin Pharmacol       Date:  1996-02       Impact factor: 4.335

9.  Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories.

Authors:  Bernard Vrijens; Gäbor Vincze; Paulus Kristanto; John Urquhart; Michel Burnier
Journal:  BMJ       Date:  2008-05-14

10.  A practice-based trial of motivational interviewing and adherence in hypertensive African Americans.

Authors:  Gbenga Ogedegbe; William Chaplin; Antoinette Schoenthaler; David Statman; David Berger; Tabia Richardson; Erica Phillips; Jacqueline Spencer; John P Allegrante
Journal:  Am J Hypertens       Date:  2008-07-24       Impact factor: 2.689

View more
  9 in total

Review 1.  Deception in clinical trials and its impact on recruitment and adherence of study participants.

Authors:  Chuen Peng Lee; Tyson Holmes; Eric Neri; Clete A Kushida
Journal:  Contemp Clin Trials       Date:  2018-08-21       Impact factor: 2.226

2.  White-Coat Effect Is Uncommon in Patients With Refractory Hypertension.

Authors:  Mohammed Siddiqui; Eric K Judd; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2017-07-10       Impact factor: 10.190

3.  Evaluating the impact of summer vacation on the visual acuity of AMD patients treated with ranibizumab.

Authors:  N Massamba; A Dirani; J Knoeri; B Pasquier; A Ingram; G Soubrane
Journal:  Eye (Lond)       Date:  2015-07-24       Impact factor: 3.775

4.  Characteristics, drug combinations and dosages of primary care patients with uncontrolled ambulatory blood pressure and high medication adherence.

Authors:  Larissa Grigoryan; Valory N Pavlik; David J Hyman
Journal:  J Am Soc Hypertens       Date:  2013-07-23

5.  The evolving clinical management of hypertension.

Authors:  Michael A Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-11-10       Impact factor: 3.738

Review 6.  Refractory and Resistant Hypertension: Antihypertensive Treatment Failure versus Treatment Resistance.

Authors:  David A Calhoun
Journal:  Korean Circ J       Date:  2016-09-28       Impact factor: 3.243

7.  Patient adherence to antihypertensive medications in upper Egypt: a cross-sectional study.

Authors:  Ahmed Hussein; Mohammad Shafiq Awad; Hossam Eldin M Mahmoud
Journal:  Egypt Heart J       Date:  2020-05-25

8.  The effect of pursed-lip breathing combined with number counting on blood pressure and heart rate in hypertensive urgency patients: A randomized controlled trial.

Authors:  Thapanawong Mitsungnern; Nipa Srimookda; Supap Imoun; Suntaraporn Wansupong; Praew Kotruchin
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-01-07       Impact factor: 3.738

Review 9.  The highly neglected burden of resistant hypertension in Africa: a systematic review and meta-analysis.

Authors:  Jobert Richie N Nansseu; Jean Jacques N Noubiap; Michel K Mengnjo; Leopold Ndemnge Aminde; Mickael Essouma; Ahmadou M Jingi; Jean Joel R Bigna
Journal:  BMJ Open       Date:  2016-09-20       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.